BAY 41-2272 a potential pharmacological tool for treating phagocyte disorders (2008)
Source: Clinical Immunology. Conference titles: Annual Meeting of Federation of Clinical Immunology Societies - FOCIS. Unidade: ICB
Assunto: IMUNOLOGIA
ABNT
PEREIRA, Paulo Vitor et al. BAY 41-2272 a potential pharmacological tool for treating phagocyte disorders. Clinical Immunology. Orlando: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 08 nov. 2024. , 2008APA
Pereira, P. V., Falcai, A., Oliveira, E., Aragão-Filho, W., Frazao, J., Marques, O., et al. (2008). BAY 41-2272 a potential pharmacological tool for treating phagocyte disorders. Clinical Immunology. Orlando: Instituto de Ciências Biomédicas, Universidade de São Paulo.NLM
Pereira PV, Falcai A, Oliveira E, Aragão-Filho W, Frazao J, Marques O, Errante P, Antunes E, Condino Neto A. BAY 41-2272 a potential pharmacological tool for treating phagocyte disorders. Clinical Immunology. 2008 ; 127[citado 2024 nov. 08 ]Vancouver
Pereira PV, Falcai A, Oliveira E, Aragão-Filho W, Frazao J, Marques O, Errante P, Antunes E, Condino Neto A. BAY 41-2272 a potential pharmacological tool for treating phagocyte disorders. Clinical Immunology. 2008 ; 127[citado 2024 nov. 08 ]